During the past decade, MultiCare Regional Cancer Center at Tacoma General Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 33 clinical trials were completed, i.e. on average, 471.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MultiCare Regional Cancer Center at Tacoma General Hospital" #1 sponsor was "SWOG Cancer Research Network" with 29 trials, followed by "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "Gynecologic Oncology Group" with 5 trials sponsored, "NSABP Foundation Inc" with 4 trials sponsored and "Radiation Therapy Oncology Group" with 4 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MultiCare Regional Cancer Center at Tacoma General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 56 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator, "Eastern Cooperative Oncology Group" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator and "NRG Oncology" with 4 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "MultiCare Regional Cancer Center at Tacoma General Hospital" are "Breast Cancer" (17 trials), "Prostate Cancer" (12 trials), "Lung Cancer" (11 trials), "Lymphoma" (7 trials) and "Ovarian Cancer" (6 trials). Many other conditions were trialed in "MultiCare Regional Cancer Center at Tacoma General Hospital" in a lesser frequency.

Most popular intervention types in "MultiCare Regional Cancer Center at Tacoma General Hospital" are "Drug" (47 trials), "Other" (23 trials), "Biological" (17 trials), "Procedure" (9 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (9 trials), "placebo" (9 trials), "docetaxel" (7 trials), "biologic sample preservation procedure" (5 trials) and "cisplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "MultiCare Regional Cancer Center at Tacoma General Hospital" are 38 trials for "All" genders, 20 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "MultiCare Regional Cancer Center at Tacoma General Hospital". undefined are not yet recruiting, 2 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 48 completed trials in MultiCare Regional Cancer Center at Tacoma General Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in MultiCare Regional Cancer Center at Tacoma General Hospital, 3 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".